» Articles » PMID: 25650671

Comparing the Phenomenology of Depressive Episodes in Bipolar I and II Disorder and Major Depressive Disorder Within Bipolar Disorder Pedigrees

Overview
Specialty Psychiatry
Date 2015 Feb 5
PMID 25650671
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In a prior study of bipolar disorder pedigrees, we demonstrated distinct clinical differences between depressive episodes in bipolar disorder and major depressive disorder (MDD), including differentiation between these conditions using the Probabilistic Approach to Bipolar Depression. The aim of this retrospective study was to compare the phenomenology of the most severe lifetime depressive episodes between bipolar I (BP-I) and II (BP-II) disorder subtypes and MDD in these pedigrees.

Method: Patients with DSM-IV diagnoses of BP-I (n = 202), BP-II (n = 44), and MDD (n = 120) from bipolar disorder pedigrees were assessed using the Diagnostic Interview for Genetic Studies between 1998 and 2012. Multivariate logistic regression was used to identify distinguishing clinical features. The utility of the Probabilistic Approach in distinguishing BP-I and BP-II depression from MDD was assessed.

Results: BP-I differed from MDD in terms of greater rates of psychomotor retardation (P < .05) and psychotic features (P < .05). BP-II was distinguished from MDD (P < .01) by the greater likelihood of mixed features. Patients with BP-II had a greater likelihood of mixed features (P < .001) and a lesser likelihood of psychomotor retardation (P < .05) compared to those with BP-I. The Probabilistic Approach significantly differentiated both BP-I and BP-II from MDD (P < .01 to P < .001, depending on cutoff) but did not robustly distinguish between BP-I and BP-II.

Conclusions: First, the differentiation of BP-II from both BP-I depression and MDD in terms of the presence of mixed symptoms is of particular interest given the current debate over "mixed specifiers" for these conditions in DSM-5. Second, the Probabilistic Approach to Bipolar Depression was demonstrated for the first time to significantly distinguish both bipolar disorder subtypes from MDD.

Citing Articles

Bipolar disorder and Lewy body dementia: case report and literature review.

Nakamura S, Sugawara H, Asada R, Hatanaka A, Hori H Front Psychiatry. 2024; 15:1409027.

PMID: 38895028 PMC: 11184140. DOI: 10.3389/fpsyt.2024.1409027.


Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder.

Wu Z, Wang J, Zhang C, Peng D, Mellor D, Luo Y BMC Psychiatry. 2024; 24(1):352.

PMID: 38730288 PMC: 11088069. DOI: 10.1186/s12888-024-05810-3.


Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study.

Wang Z, Zhang D, Du Y, Wang Y, Huang T, Ng C Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259431 PMC: 9966274. DOI: 10.3390/ph16020287.


Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness.

Chakrabarti S World J Psychiatry. 2022; 12(12):1335-1355.

PMID: 36579354 PMC: 9791613. DOI: 10.5498/wjp.v12.i12.1335.


Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Chakrabarti S, Singh N World J Psychiatry. 2022; 12(9):1204-1232.

PMID: 36186500 PMC: 9521535. DOI: 10.5498/wjp.v12.i9.1204.